Maternal Global Methylation Status and Risk of Congenital Heart Diseases
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 112 (2) , 277-283
Abstract
OBJECTIVE: To investigate whether the association between the maternal methylation status as reflected by low S-adenosylmethionine and high S-adenosylhomocysteine, is detrimental for cardiogenesis and congenital heart disease (CHD) in the offspring. METHODS: As part of a case–control study in the western part of the Netherlands, we evaluated 231 mothers of children with CHD and 315 control mothers of nonmalformed children. The total case group was analyzed and stratified into isolated (n=180) and nonisolated CHDs (n=51). The latter subgroup was further subdivided into Nonsyndromic (n=20), Down Syndrome (n=19), and Other Syndromes (n=12). A multivariable general linear model was used to test for differences between the case groups and controls. All analyses were adjusted for current B vitamin supplement use. RESULTS: Plasma total homocysteine was significantly different between the total case group (median, range 10.3, 4.0–43.8, P=.026) and the nonisolated cases (11.1, 5.5–43.8, P=.006) compared with the controls (10.0, 5.3–42.0). The subgroup of Down Syndrome presented significantly higher total homocysteine and S-adenosylhomocysteine levels and a lower S-adenosylmethionine/S-adenosylhomocysteine ratio than controls. CONCLUSION: Maternal hyperhomocysteinemia, and not hypomethylation, is a risk factor for having a child with CHD. Maternal hypomethylation, however, seems to be associated with offspring having CHD and Down syndrome. LEVEL OF EVIDENCE: IIKeywords
This publication has 28 references indexed in Scilit:
- Maternal hyperhomocysteinaemia is a risk factor for congenital heart diseaseBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Maternal Homocysteine and Congenital Heart DefectsJACC, 2006
- Cardiac outflow tract malformations in chick embryos exposed to homocysteineCardiovascular Research, 2004
- Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survivalProgress in Pediatric Cardiology, 2003
- Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gapsAmerican Journal of Medical Genetics Part A, 2003
- Nutrient-gene interactions in early pregnancy: a vascular hypothesisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- Elevation in S-Adenosylhomocysteine and DNA Hypomethylation: Potential Epigenetic Mechanism for Homocysteine-Related PathologyThe Journal of Nutrition, 2002
- Folic Acid Antagonists during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2000
- Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA HypomethylationJournal of Biological Chemistry, 2000
- Congenital heart defects and maternal derangement of homocysteine metabolismThe Journal of Pediatrics, 1999